Closed
SectorHealthcare
23 1.55
24h
Min
21.84
Max
23.08
Income | 21M -36M |
---|---|
Sales | 16M 213M |
EPS | -0.29 |
Profit margin | -17.105 |
Employees | 705 |
EBITDA | 20M -24M |
Recommendations | Buy |
---|---|
12 Months Forecast | +86.42% upside |
Next Earnings | 1 maj 2025 |
---|
Market Cap | -563M 2.8B |
---|---|
Previous open | 21.45 |
Previous close | 23 |
By Acuity
44%
56%
161 / 386 Ranking in Healthcare
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 42.28 USD 86.42%
High 75 USD
Low 25 USD
Based on 20 Wall Street analysts offering 12 month price targets forApellis Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$